# Concord Acquisition Corp II: financial statements, quarterly CNDA · OTC · CIK 1851959 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cnda.md) · [Financials](/companies/cnda/financials.md) · [Filings](/companies/cnda/filings.md) · [Insiders](/companies/cnda/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnda/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating income | $k | [(1,392)](/filings/0001410578-24-001719.md) | [(302) d](/filings/0001410578-25-000156.md) | [(345)](/filings/0001410578-25-001078.md) | [(565)](/filings/0001410578-25-001567.md) | [(839)](/filings/0001104659-25-107779.md) | [(401) d](/filings/0001104659-26-033994.md) | [(474)](/filings/0001104659-26-060465.md) | [(359)](/filings/0001104659-26-096009.md) | [(255)](/filings/0001104659-25-107779.md) | [(177) d](/filings/0001104659-26-033994.md) | [(314)](/filings/0001104659-26-060465.md) | [(58.3)](/filings/0001104659-26-096009.md) | | Income tax | $k | [638](/filings/0001410578-24-001719.md) | [347 d](/filings/0001410578-25-000156.md) | [344](/filings/0001410578-25-001078.md) | [252](/filings/0001410578-25-001567.md) | [42.5](/filings/0001104659-25-107779.md) | [34.0 d](/filings/0001104659-26-033994.md) | [20.9](/filings/0001104659-26-060465.md) | [(0.1)](/filings/0001104659-26-096009.md) | [(0.0)](/filings/0001104659-25-107779.md) | [5.5 d](/filings/0001104659-26-033994.md) | not reported | not reported | | Net income | $k | [112](/filings/0001410578-24-001719.md) | [1,256 d](/filings/0001410578-25-000156.md) | [690](/filings/0001104659-25-107779.md) | [1,107](/filings/0001104659-25-107779.md) | [(4,483)](/filings/0001104659-25-107779.md) | [1,921 d](/filings/0001104659-26-033994.md) | [(991)](/filings/0001104659-26-096009.md) | [1,453](/filings/0001104659-26-096009.md) | [1,297](/filings/0001104659-25-107779.md) | [(1,203) d](/filings/0001104659-26-033994.md) | [(87.3)](/filings/0001104659-26-096009.md) | [1,148](/filings/0001104659-26-096009.md) | - Operating income: us-gaap:OperatingIncomeLoss - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.6](/filings/0001410578-23-002227.md) | [0.4](/filings/0001410578-25-000156.md) | [0.1](/filings/0001410578-24-000588.md) | [0.5](/filings/0001410578-24-001173.md) | [0.7](/filings/0001410578-24-001719.md) | [0.5](/filings/0001104659-26-033994.md) | [0.1](/filings/0001410578-25-001078.md) | [0.0](/filings/0001410578-25-001567.md) | [0.1](/filings/0001104659-25-107779.md) | [0.2](/filings/0001104659-26-096009.md) | [0.1](/filings/0001104659-26-060465.md) | [0.1](/filings/0001104659-26-096009.md) | | Current assets | $m | [0.7](/filings/0001410578-23-002227.md) | [0.4](/filings/0001410578-25-000156.md) | [0.1](/filings/0001410578-24-000588.md) | [0.7](/filings/0001410578-24-001173.md) | [0.9](/filings/0001410578-24-001719.md) | [0.9](/filings/0001104659-26-033994.md) | [0.5](/filings/0001410578-25-001078.md) | [0.2](/filings/0001410578-25-001567.md) | [0.2](/filings/0001104659-25-107779.md) | [0.3](/filings/0001104659-26-096009.md) | [0.2](/filings/0001104659-26-060465.md) | [0.2](/filings/0001104659-26-096009.md) | | Total assets | $m | [153](/filings/0001410578-23-002227.md) | [154](/filings/0001410578-25-000156.md) | [156](/filings/0001410578-24-000588.md) | [24.1](/filings/0001410578-24-001173.md) | [24.6](/filings/0001410578-24-001719.md) | [24.7](/filings/0001104659-26-033994.md) | [0.6](/filings/0001410578-25-001078.md) | [0.3](/filings/0001410578-25-001567.md) | [0.3](/filings/0001104659-25-107779.md) | [0.4](/filings/0001104659-26-096009.md) | [0.3](/filings/0001104659-26-060465.md) | [0.3](/filings/0001104659-26-096009.md) | | Current liabilities | $m | [2.6](/filings/0001410578-23-002227.md) | [2.5](/filings/0001410578-25-000156.md) | [3.0](/filings/0001410578-24-000588.md) | [4.3](/filings/0001410578-24-001173.md) | [5.4](/filings/0001410578-24-001719.md) | [5.2](/filings/0001104659-26-033994.md) | [5.5](/filings/0001410578-25-001078.md) | [5.6](/filings/0001410578-25-001567.md) | [5.8](/filings/0001104659-25-107779.md) | [6.1](/filings/0001104659-26-096009.md) | [6.3](/filings/0001104659-26-060465.md) | [6.4](/filings/0001104659-26-096009.md) | | Total liabilities | $m | [14.0](/filings/0001410578-23-002227.md) | [8.6](/filings/0001410578-25-000156.md) | [9.3](/filings/0001410578-24-000588.md) | [10.6](/filings/0001410578-24-001173.md) | [12.2](/filings/0001410578-24-001719.md) | [9.8](/filings/0001104659-26-033994.md) | [10.7](/filings/0001410578-25-001078.md) | [9.0](/filings/0001410578-25-001567.md) | [7.7](/filings/0001104659-25-107779.md) | [9.0](/filings/0001104659-26-096009.md) | [9.0](/filings/0001104659-26-060465.md) | [7.9](/filings/0001104659-26-096009.md) | | Shareholders' equity | $m | [(13.2)](/filings/0001410578-24-001719.md) | [(8.2)](/filings/0001104659-26-033994.md) | [(8.8)](/filings/0001104659-25-107779.md) | [(10.0)](/filings/0001104659-25-107779.md) | [(11.2)](/filings/0001104659-25-107779.md) | [(9.0)](/filings/0001104659-26-096009.md) | [(10.3)](/filings/0001104659-26-096009.md) | [(8.8)](/filings/0001104659-26-096009.md) | [(7.5)](/filings/0001104659-25-107779.md) | [(8.7)](/filings/0001104659-26-096009.md) | [(8.8)](/filings/0001104659-26-096009.md) | [(7.7)](/filings/0001104659-26-096009.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(974) d](/filings/0001410578-24-001719.md) | [(639) d](/filings/0001410578-25-000156.md) | [(289)](/filings/0001410578-25-001078.md) | [(899) d](/filings/0001410578-25-001567.md) | [214 d](/filings/0001104659-25-107779.md) | [(572) d](/filings/0001104659-26-033994.md) | [(691)](/filings/0001104659-26-060465.md) | [(114) d](/filings/0001104659-26-096009.md) | [61.8 d](/filings/0001104659-25-107779.md) | [(185) d](/filings/0001104659-26-033994.md) | [(132)](/filings/0001104659-26-060465.md) | [58.6 d](/filings/0001104659-26-096009.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.